Khambatta Securities has issued a HOLD recommendation for Krishna Institute of Medical Sciences (KIMS) with a target price of Rs 572, indicating a potential upside of 3.6% from the current price of Rs 552.1, advising investors to hold their positions in the stock.
Stay informed with our financial updates, stocks, bonds, commodities. Get global & political insights. Follow us & enable notifications for the latest updates.
Newsvoir Metalogic PMS, a renowned steel market intelligence firm, is proud to announce the hosting of the National Conference on Steel in Infrastructure. Scheduled for […]
Infosys to Settle ₹32,403.46 Crore IGST for 2017-18 to 2021-22 Infosys is required to pay Integrated Goods and Services Tax (IGST) of ₹32,403.46 crore for […]
In August, foreign investors increased their stakes in India’s information technology (IT) and pharmaceutical sectors, expecting a potential rate cut by the U.S. Federal Reserve, […]